Updated results from TIGER-X, a phase I/II open label study of rociletinib in patients (pts) with advanced, recurrent T790M-positive non-small cell lung cancer (NSCLC).

Jonathan Wade Goldman; Jean-Charles Soria; Heather A. Wakelee; D. Ross Camidge; Shirish M. Gadgeel; Helena Alexandra Yu; Karen L. Reckamp; Vassiliki Papadimitrakopoulou; Maurice Perol; Sai-Hong Ignatius Ou; Shannon L. Matheny; Darrin Despain; Jeffrey D. Isaacson; Sergey Yurasov; Lindsey Rolfe; Lecia V. Sequist

doi:10.1200/jco.2016.34.15_suppl.9045

Updated results from TIGER-X, a phase I/II open label study of rociletinib in patients (pts) with advanced, recurrent T790M-positive non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.9045 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 9045-9045 ◽

Cited By ~ 3

Author(s):

Jonathan Wade Goldman ◽

Jean-Charles Soria ◽

Heather A. Wakelee ◽

D. Ross Camidge ◽

Shirish M. Gadgeel ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Phase I open-label study evaluating the safety, pharmacokinetics, and preliminary efficacy of ABBV-181 and rovalpituzumab tesirine (ROVA-T) in patients with small cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdz264.012 ◽

2019 ◽

Vol 30 ◽

pp. v715-v716

Author(s):

E. Calvo ◽

A. Spira ◽

H. Prenen ◽

Y. Ohe ◽

S. Rottey ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer

Frontiers in Oncology ◽

10.3389/fonc.2019.01256 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 4

Author(s):

Jonathan W. Goldman ◽

David M. Waterhouse ◽

Ben George ◽

Peter J. O'Dwyer ◽

Rafia Bhore ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

Download Full-text

A Phase 2 Randomized Open-Label Study of Ramucirumab (IMC 1121b; RAM) in Combination with Platinum-Based Chemotherapy in Patients (PTS) with Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC): Results From Non-Squamous (NSQ) PTS (NCT01160744)

Annals of Oncology ◽

10.1016/s0923-7534(20)33839-4 ◽

2012 ◽

Vol 23 ◽

pp. ix408 ◽

Cited By ~ 1

Author(s):

R. Doebele ◽

D. Spigel ◽

M. Tehfe ◽

S. Thomas ◽

M. Reck ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Platinum Based Chemotherapy

Download Full-text

Second-line erlotinib in patients with advanced non-small-cell lung cancer (NSCLC): Results from a large, open-label study

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.19002 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19002-19002

Author(s):

L. Crinò ◽

M. Boyer ◽

W. E. Eberhardt ◽

Z. Balikó ◽

E. F. Smit

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

A randomized open-label study of gefitinib versus docetaxel in patients with advanced/metastatic non-small cell lung cancer (NSCLC) who have previously received platinum-based chemotherapy

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.8025 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 8025-8025 ◽

Cited By ~ 8

Author(s):

D. Lee ◽

S. Kim ◽

K. Park ◽

J. Kim ◽

J. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Platinum Based Chemotherapy

Download Full-text

Randomized, open-label study of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small cell lung cancer (NSCLC) of nonsquamous histology.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps290 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS290-TPS290 ◽

Cited By ~ 1

Author(s):

R. Zinner ◽

S. Saxman ◽

G. Peng ◽

W. F. Ortuzar

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

An open-label study on safety and tolerability of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdx386.009 ◽

2017 ◽

Vol 28 ◽

pp. v542 ◽

Cited By ~ 1

Author(s):

I. Okamoto ◽

H. Udagawa ◽

S. Kanda ◽

T.H. Han ◽

I. Lakatos ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Japanese Patients ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

Abstract CT267: A phase 1b/2, open-label study of bintrafusp alfa with chemotherapy in patients with stage IV non-small cell lung cancer

10.1158/1538-7445.am2020-ct267 ◽

2020 ◽

Author(s):

Fabrice Barlesi ◽

Sandrine Hiret ◽

Christian Rolfo ◽

Italia Grenga ◽

Andre Köenig ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stage Iv ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase 1B

Download Full-text

Biomarker analyses from an open-label study of erlotinib in advanced non-small-cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.19012 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19012-19012

Author(s):

N. van Zandwijk ◽

W. Su ◽

R. Rooneem ◽

B. Mehi|Dc ◽

F. A. Franke

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

A phase 1b open-label study to evaluate the safety and tolerability of MEDI4736, an anti–PD-L1 antibody, in combination with tremelimumab in subjects with advanced non–small cell lung cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e19137 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e19137-e19137 ◽

Cited By ~ 3

Author(s):

Mary Colleen Pinder ◽

Naiyer A. Rizvi ◽

Sarah B. Goldberg ◽

Ani Sarkis Balmanoukian ◽

Rajesh Narwal ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Phase 1B

Download Full-text